We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.37B
AUM Growth
+$62.8M
Cap. Flow
-$112M
Cap. Flow %
-2.09%
Top 10 Hldgs %
20.35%
Holding
855
New
121
Increased
189
Reduced
310
Closed
120

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$45.7M
2
IDXX icon
Idexx Laboratories
IDXX
+$34.3M
3
CAH icon
Cardinal Health
CAH
+$30.2M
4
AMAT icon
Applied Materials
AMAT
+$24.5M
5
ELV icon
Elevance Health
ELV
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 18.73%
2 Financials 15.53%
3 Industrials 13.23%
4 Consumer Discretionary 12.83%
5 Technology 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$146M 2.72%
1,304,976
-31,313
-2% -$3.3M
UNP icon
2
Union Pacific
UNP
$183B
$143M 2.67%
1,202,097
-15,400
-1% -$1.77M
JPM icon
3
JPMorgan Chase
JPM
$942B
$116M 2.16%
1,851,857
+217,543
+13% +$13.1M
MA icon
4
Mastercard
MA
$518B
$111M 2.07%
1,286,754
-34,775
-3% -$2.84M
MIC
5
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$110M 2.05%
1,547,410
+85,806
+6% +$5.84M
CMG icon
6
Chipotle Mexican Grill
CMG
$47.1B
$109M 2.04%
7,998,000
+351,900
+5% +$4.6M
SBAC icon
7
SBA Communications
SBAC
$19.8B
$92M 1.71%
831,048
-13,705
-2% -$1.54M
SBUX icon
8
Starbucks
SBUX
$122B
$89.4M 1.66%
2,178,756
+166,684
+8% +$6.51M
TWX
9
DELISTED
Time Warner Inc
TWX
$88.6M 1.65%
1,037,412
+128,686
+14% +$10.3M
AMG icon
10
Affiliated Managers Group
AMG
$9.58B
$87.1M 1.62%
410,598
+9,217
+2% +$1.83M
MSFT icon
11
Microsoft
MSFT
$3.75T
$86.7M 1.61%
1,866,067
+289,717
+18% +$13.6M
BA icon
12
Boeing
BA
$166B
$85.8M 1.6%
660,250
+94,881
+17% +$12M
AMT icon
13
American Tower
AMT
$81.2B
$84.4M 1.57%
853,873
+8,497
+1% +$835K
MMP
14
DELISTED
Magellan Midstream Partners, L.P.
MMP
$83.9M 1.56%
1,014,724
-26,133
-3% -$2.14M
REGN icon
15
Regeneron Pharmaceuticals
REGN
$83.2B
$82.1M 1.53%
200,071
-5,573
-3% -$2.19M
ABBV icon
16
AbbVie
ABBV
$456B
$79.6M 1.48%
1,216,233
+107,520
+10% +$6.78M
ELV icon
17
Elevance Health
ELV
$86.6B
$79.5M 1.48%
632,891
+195,392
+45% +$24.1M
AMP icon
18
Ameriprise Financial
AMP
$49.1B
$78.6M 1.46%
594,444
+4,167
+0.7% +$527K
META icon
19
Meta Platforms (Facebook)
META
$1.45T
$78.2M 1.46%
1,002,278
-32,327
-3% -$2.47M
AAPL icon
20
Apple
AAPL
$4.59T
$77.4M 1.44%
2,804,520
+654,736
+30% +$17.8M
BFH icon
21
Bread Financial
BFH
$4.15B
$75.6M 1.41%
331,347
-5,697
-2% -$1.25M
TSCO icon
22
Tractor Supply
TSCO
$18.1B
$73.3M 1.37%
4,651,050
-325,075
-7% -$4.66M
WBA
23
DELISTED
Walgreens Boots Alliance
WBA
$73.2M 1.36%
959,971
-4,308
-0.4% -$288K
CMCSA icon
24
Comcast
CMCSA
$93.7B
$73.1M 1.36%
2,520,330
+133,422
+6% +$3.66M
MON
25
DELISTED
Monsanto Co
MON
$72.8M 1.36%
609,016
-96,110
-14% -$11.2M

Similar funds

Geneva Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Geneva Advisors held 855 positions worth $5.37B, up 1.2% from $5.31B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneva Advisors's Q4 2014 filing shows 121 new, 189 increased, 310 reduced and 120 closed positions. Its largest new stake was Idexx Laboratories: 488,650 shares worth $36.2M. The largest sale was LyondellBasell Industries, an estimated $73.1M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q4 2014 buy was Idexx Laboratories: 488,650 shares worth $36.2M.
  • Geneva Advisors added most to Alibaba in Q4 2014, an estimated $45.7M increase.
  • Geneva Advisors's biggest Q4 2014 reduction was LyondellBasell Industries, cutting an estimated $73.1M.
  • Geneva Advisors fully exited Community Health Systems in Q4 2014, selling an estimated $13M.
  • Geneva Advisors's ten largest holdings make up 20% of its $5.37B portfolio in Q4 2014.
  • Geneva Advisors opened 121 new positions and closed 120 in Q4 2014.
  • Geneva Advisors's portfolio value rose 1.2% quarter-over-quarter to $5.37B.

Based on Geneva Advisors's 13F filing for Q4 2014, filed 2 Feb 2015.